DOCSLIB.ORG

Glucocorticoids Recruit Tgfbr3 and Smad1 to Shift Transforming Growth Factor-Β Signaling from the Tgfbr1/Smad2/3 Axis to the Acvrl1/Smad1 Axis in Lung Fibroblasts

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Glucocorticoids Recruit Tgfbr3 and Smad1 to Shift Transforming Growth Factor-Β Signaling from the Tgfbr1/Smad2/3 Axis to the Acvrl1/Smad1 Axis in Lung Fibroblasts Glucocorticoids recruit Tgfbr3 and Smad1 to shift transforming growth factor-β signaling from the Tgfbr1/Smad2/3 axis to the Acvrl1/Smad1 axis in lung fibroblasts Inauguraldissertation zur Erlangung des Grades eines Doktors der Medizin des Fachbereichs Medizin der Justus-Liebig-Universität Gießen vorgelegt von Schwartze, Julian Tristan aus Langen (Hessen), Deutschland Gießen (2014) Aus dem Department of Lung Development and Remodelling, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany; Department of Internal Medicine (Pulmonology), University of Giessen and Marburg Lung Center, German Center for Lung Research, Giessen, Germany. Leiter/Direktor: Prof. Dr. med. Werner Seeger Gutachter: Prof. Dr. med. Werner Seeger Gutachter: Prof. Dr. Klaus T. Preissner Tag der Disputation: 31.07.2015 Table of contents I I. Table of contents I. Table of contents ................................................................................................ I II. List of figures .................................................................................................... VI III. List of tables ................................................................................................... VIII IV. List of abbreviations ......................................................................................... IX V. Summary ........................................................................................................... XI VI. Zusammenfassung .......................................................................................... XII 1. Introduction ............................................................................................................ 1 1.1 Background .......................................................................................................... 1 1.2 Transforming growth factor-β ............................................................................. 1 1.2.1 TGF-β ligands ............................................................................................. 2 1.2.2 Activation of TGF-β ..................................................................................... 2 1.2.3 TGF-β receptors .......................................................................................... 4 1.2.4 Signal transduction mechanism and Smad proteins .................................... 4 1.2.5 Gene regulation ........................................................................................... 6 1.2.6 TGF-β co-receptors ..................................................................................... 7 1.2.7 Betaglycan: an accessory TGF-β receptor .................................................. 7 1.2.8 Tgfbr1 versus Acvrl1 signaling ..................................................................... 8 1.2.9 TGF-β signaling in lung development .......................................................... 9 1.2.10 TGF-β signaling in lung disease ................................................................ 9 1.2.11 Fibroblast-to-myofibroblast differentiation ................................................ 12 1.3 Glucocorticoids .................................................................................................. 13 1.3.1 Glucocorticoid effects in the human body .................................................. 13 1.3.2 Glucocorticoid cell signaling ...................................................................... 13 1.3.3 The intracellular glucocorticoid receptor .................................................... 13 1.3.4 Signal transduction mechanism ................................................................. 14 1.3.5 Regulation of glucocorticoid concentrations in the body ............................ 15 1.3.6 Cortisol synthesis ...................................................................................... 15 1.3.7 Cortisol derivatives .................................................................................... 16 1.3.8 General clinical use of glucocorticoids ....................................................... 16 1.3.9 Adverse effects of glucocorticoids ............................................................. 16 1.3.10 Glucocorticoids in TGF-β-related lung pathologies and development ...... 17 Table of contents II 2. Aim of the study ................................................................................................... 20 3. Materials and methods ......................................................................................... 21 3.1 Materials .............................................................................................................. 21 3.1.1 Equipment ................................................................................................. 21 3.1.2 Reagents ................................................................................................... 22 3.2 Methods .............................................................................................................. 24 3.2.1 Cell culture ................................................................................................ 24 3.2.1.1 NIH/3T3 mouse fibroblast-like cells ..................................................... 24 3.2.1.2 Isolation of primary mouse lung fibroblasts ......................................... 24 3.2.1.3 Cultivating primary mouse lung fibroblasts .......................................... 25 3.2.1.4 Primary human lung fibroblasts ........................................................... 26 3.2.1.5 Primary human pulmonary artery endothelial cells .............................. 26 3.2.1.6 Primary human pulmonary artery smooth muscle cells ....................... 26 3.2.1.7 H441 human Clara cell-like airway epithelial cells ............................... 26 3.2.1.8 Experimental cell culture setup ........................................................... 26 3.2.2 mRNA isolation ......................................................................................... 27 3.2.2.1 mRNA isolation from cells ................................................................... 27 3.2.2.2 mRNA isolation from mouse lung, heart, liver, and kidney................... 27 3.2.3 Determining mRNA concentrations ........................................................... 27 3.2.4 Reverse transcription reaction ................................................................... 27 3.2.5 Real-time polymerase chain reaction ......................................................... 28 3.2.6 Determining mRNA expression by StepOne Software ............................... 29 3.2.7 Protein isolation ......................................................................................... 30 3.2.7.1 Protein isolation from cells .................................................................. 30 3.2.7.2 Protein isolation from mouse lungs ..................................................... 30 3.2.8 Determining protein concentrations ........................................................... 30 3.2.9 SDS polyacrylamide gel electrophoresis ................................................... 31 3.2.10 Immunoblot analysis ................................................................................ 32 3.2.10.1 Immunoblotting ................................................................................. 32 3.2.10.2 Protein visualization .......................................................................... 33 3.2.10.3 Membrane stripping .......................................................................... 34 3.2.10.4 Determining protein density by Multi Gauge MFC Software .............. 34 3.2.11 Transfection of cells with small interfering RNA ....................................... 34 3.2.11.1 Experimental cell culture setup for knock-down experiments ............ 35 3.2.12 Transfection of cells with TGFBR3-expressing plasmid constructs .......... 35 Table of contents III 3.2.12.1 Experimental cell culture setup for overexpression experiments ....... 35 3.2.13 Dual luciferase ratio assay analysis ......................................................... 36 3.2.13.1 Transfection of cells with corresponding plasmids ............................. 36 3.2.13.2 Experimental cell culture setup for dual luciferase assay................... 37 3.2.13.3 Experimental cell culture setup with small interfering RNA ................ 37 3.2.13.4 Experimental cell culture setup with TGFBR3-expressing plasmids .. 38 3.2.13.5 Cell lysis ............................................................................................ 38 3.2.13.6 Determining luciferase activity ........................................................... 38 3.2.14 Animal studies ......................................................................................... 38 3.2.14.1 Pulmonary effects of dexamethasone in mice ................................... 38 3.2.14.2 Organ storage ................................................................................... 39 3.2.15 Statistical analysis ................................................................................... 39 4. Results .................................................................................................................. 40 4.1 Glucocorticoids inhibit classical Tgfbr1/Smad2/3 signaling in NIH/3T3 mouse fibroblast-like cells....................................................................................... 40 4.1.1 p(CAGA)9 induction analysis by dual luciferase assay ............................... 40 4.1.2 Immunoblot analysis
Load more

Recommended publications
  • Recombinant Human TGF-Beta 2 Protein
    ACROBiosystems Recombinant Human TGF-Beta 2 Protein Cat. # TG2-H4213 For Research and Further Cell Culture Manufacturing Use Source: Bioactivity: Recombinant Human TGF Beta 2 Protein (rhTGFB2) The bio-activity was determined by its ability to Ala 303 - Ser 414 (Accession # NP_003229.1) was inhibit IL-4 induced HT-2 cell proliferation. ED50<0.1 produced in human HEK293 cells at ACRObiosystems. ng/ml, corresponding to a specific activity of >1X107 Unit/mg Molecular Characterization: Formulation: rhTGFB2 contains no “tags” and has a calculated MW of 12.7 kDa (monomer). DTT-reduced protein migrates Lyophilized from 0.22 μm filtered solution in TFA, as a 13 kDa polypeptide and the non-reduced cystine- acetonitrile. Normally Mannitol or Trehalose are linked homodimer migrates as a 25 kDa protein. added as protectants before lyophilization. Contact us for customized product format or Endotoxin: formulation. Less than 1.0 EU per μg of the rhTGFB2 by the LAL Reconstitution : method. See Certificate of Analysis for details of Purity: reconstitution instruction and specific concentration. >98% as determined by SDS-PAGE of reduced (+) and Storage: non-reduced (-) rhTGFB2. Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: SDS-PAGE: • 4-8℃ for 1 year in lyophilized state The purity of rhTGFB2 • 4-8℃ for 1 month under sterile conditions after was determined by SDS- reconstitution PAGE of reduced (+) and • -20 ℃ to -70 ℃ for 3 months under sterile non-reduced (-) rhTGFB2 conditions after reconstitution and staining overnight with Coomassie Blue. Background: Transforming growth factor beta 2 ( TGFB2) is also known as TGF-β2, TGF-beta2, Glioblastoma-derived T-cell suppressor factor, G-TSF, BSC-1 cell growth inhibitor, Polyergin, Cetermin, and is a polypeptide member of the transforming growth factor beta superfamily of cytokines.
    [Show full text]
  • Bmpr Encodes a Type I Bone Morphogenetic Protein Receptor That Is Essential for Gastrulation During Mouse Embryogenesis
    Downloaded from genesdev.cshlp.org on October 8, 2021 - Published by Cold Spring Harbor Laboratory Press Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis Yuji Mishina, ~ Atsushi Suzuki, 2 Naoto Ueno, 2 and Richard R. Behringer ~'3 1Department of Molecular Genetics, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas 77030 USA; ~Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060, Japan Bone morphogenetic proteins (BMPs) are secreted proteins that interact with cell-surface receptors and are believed to play a variety of important roles during vertebrate embryogenesis. Bmpr, also known as ALK-3 and Brk-1, encodes a type I transforming growth factor-~ (TGF-[3) family receptor for BMP-2 and BMP-4. Bmpr is expressed ubiquitously during early mouse embryogenesis and in most adult mouse tissues. To study the function of Bmpr during mammalian development, we generated Bmpr-mutant mice. After embryonic day 9.5 (E9.5), no homozygous mutants were recovered from heterozygote matings. Homozygous mutants with morphological defects were first detected at E7.0 and were smaller than normal. Morphological and molecular examination demonstrated that no mesoderm had formed in the mutant embryos. The growth characteristics of homozygous mutant blastocysts cultured in vitro were indistinguishable from those of controls; however, embryonic ectoderm (epiblast) cell proliferation was reduced in all homozygous mutants at E6.5 before morphological abnormalities had become prominent. Teratomas arising from E7.0 mutant embryos contained derivatives from all three germ layers but were smaller and gave rise to fewer mesodermal cell types, such as muscle and cartilage, than controls.
    [Show full text]
  • Redalyc.Possible Role of Noggin Gene in Mandibular Development
    Universitas Odontológica ISSN: 0120-4319 [email protected] Pontificia Universidad Javeriana Colombia Gutiérrez Prieto, Sandra; Torres López, Diana; Gómez Rodríguez, Mariluz; García Robayo, Adriana Possible Role of Noggin Gene in Mandibular Development Universitas Odontológica, vol. 34, núm. 73, julio-diciembre, 2015, pp. 21-31 Pontificia Universidad Javeriana Bogotá, Colombia Available in: http://www.redalyc.org/articulo.oa?id=231247071014 How to cite Complete issue Scientific Information System More information about this article Network of Scientific Journals from Latin America, the Caribbean, Spain and Portugal Journal's homepage in redalyc.org Non-profit academic project, developed under the open access initiative Possible Role of Noggin Gene in Mandibular Development Posible papel del gen noggin en el desarrollo mandibular Possível papel do gene noggin no desenvolvimento mandibular 21 Sandra Gutiérrez Prieto ABSTRACT Odontóloga, magistra y PhD en Background: Noggin (Nog) gene is one of the antagonists of bone morphogenic proteins (BMPs) Ciencias Biológicas, docente and its function is to modulate the signs. When Nog’s action is ineffective, an excessive activity investigadora del Centro de of BMPs occur causing serious developmental abnormalities. Studies have shown that Nog is Investigaciones Odontológicas, critical for chondrogenesis, osteogenesis, and joint training and appears to be involved in the 2027-3444 | e-ISSN 0120-4319 ISSN . Pontificia Universidad Javeriana, growth of craniofacial structures, including the jaw. There are in the literature a few studies Bogotá, Colombia. about the relationship between Nog and its role in mandibular development. Purpose: To r e - views the molecular factors involved in the jaw development. Method: Focusing primarily on Diana Torres López BMPs, their function, and signaling pathway as Nog regulates this path.
    [Show full text]
  • In Vivo Imaging of Tgfβ Signalling Components Using Positron
    REVIEWS Drug Discovery Today Volume 24, Number 12 December 2019 Reviews KEYNOTE REVIEW In vivo imaging of TGFb signalling components using positron emission tomography 1 1 2 Lonneke Rotteveel Lonneke Rotteveel , Alex J. Poot , Harm Jan Bogaard , received her MSc in drug 3 1 discovery and safety at the Peter ten Dijke , Adriaan A. Lammertsma and VU University in 1 Amsterdam. She is Albert D. Windhorst currently finishing her PhD at the VU University 1 Department of Radiology and Nuclear Medicine, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands Medical Center (VUmc) 2 under the supervision of A. Pulmonary Medicine, Institute for Cardiovascular Research, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands D. Windhorst and Adriaan A. Lammertsma. Her 3 research interest is on the development of positron Department of Cell and Chemical Biology, Oncode Institute, Leiden University Medical Center, Leiden, The emission tomography (PET) tracers that target Netherlands selectively the activin receptor-like kinase 5 in vitro and in vivo. Alex J. Poot obtained his The transforming growth factor b (TGFb) family of cytokines achieves PhD in medicinal chemistry homeostasis through a careful balance and crosstalk with complex from Utrecht University. As postdoctoral researcher at signalling pathways. Inappropriate activation or inhibition of this pathway the VUmc, Amsterdam, he and mutations in its components are related to diseases such as cancer, developed radiolabelled anticancer drugs for PET vascular diseases, and developmental disorders. Quantitative imaging of imaging. In 2014, he accepted a research expression levels of key regulators within this pathway using positron fellowship from Memorial Sloan Kettering Cancer 13 emission tomography (PET) can provide insights into the role of this Center, New York to develop C-labelled probes for tumour metabolism imaging with magnetic resonance in vivo pathway , providing information on underlying pathophysiological imaging (MRI).
    [Show full text]
  • Role of TGF-Β3 in the Regulation of Immune Responses T
    Role of TGF-β3 in the regulation of immune responses T. Okamura1,2, K. Morita1, Y. Iwasaki1, M. Inoue1, T. Komai1, K. Fujio1, K. Yamamoto1 1Department of Allergy and ABSTRACT ences, indicating their non-redundancy Rheumatology, Graduate School of Transforming growth factor-betas (12-16). The TGF-βs have opposite ef- Medicine, The University of Tokyo, (TGF-βs) are multifunctional cytokines fects on tissue fibrosis. Wound-healing Tokyo, Japan; that have been implicated in the regu- experiments revealed that TGF-β1 2Max Planck-The University of Tokyo Center for Integrative Inflammology, lation of a broad range of biological and TGF-β2 cause fibrotic scarring The University of Tokyo, Tokyo, Japan. processes, including cell proliferation, responses and that TGF-β3 induces a Tomohisa Okamura, MD, PhD cell survival, and cell differentiation. scar-free response (17). Both TGF-β1 Kaoru Morita, MD The three isoforms identified in mam- and -β2 activate the collagen α2 (I) Yukiko Iwasaki, MD, PhD mals, TGF-β1, TGF-β2, and TGF-β3, gene promoter, resulting in increased Mariko Inoue, MD have high sequence homology, bind to collagen synthesis (18). It was also re- Toshihiko Komai, MD the same receptors, and show similar ported that TGF-β1, but not TGF-β3, is Keishi Fujio, MD, PhD biological functions in many in vitro a crucial factor in the development of Kazuhiko Yamamoto, MD, PhD studies. However, analysis of the in vivo pulmonary fibrosis (19). Most of the in- Please address correspondence to: functions of the three isoforms and mice formation on the immunological activ- Keishi Fujio, MD, PhD, deficient for each cytokine reveals strik- Department of Allergy and ity of TGF-βs derives from studies of Rheumatology, ing differences, illustrating their unique TGF-β1 and, in part, TGF-β2, whereas Graduate School of Medicine, biological importance and functional recent investigations have begun to il- The University of Tokyo, non-redundancy.
    [Show full text]
  • Transforming Growth Factor-Beta Family Members Are Regulated During Induced Luteolysis in Cattle
    a https://doi.org/10.21451/1984-3143-AR2018-0146 Original Article Animal Reproduction Anim Reprod. 2019;16(4):829-837 Transforming growth factor-beta family members are regulated during induced luteolysis in cattle Cristina Sangoi Haas1, Monique Tomazele Rovani1 , Gustavo Freitas Ilha2 , Kalyne Bertolin2 , Juliana Germano Ferst2 , Alessandra Bridi2 , Vilceu Bordignon3 , Raj Duggavathi3, Alfredo Quites Antoniazzi2 , Paulo Bayard Dias Gonçalves2 , Bernardo Garziera Gasperin1* 1Universidade Federal de Pelotas, Departamento de Patologia Animal, Capão do Leão, RS, Brasil 2Universidade Federal de Santa Maria, Laboratório de Biotecnologia e Reprodução Animal, Santa Maria, RS, Brasil 3McGill University, Department of Animal Science, Sainte-Anne-de-Bellevue, QC, Canada Abstract cell death and tissue remodeling (Miyamoto et al., 2009; Skarzynski and Okuda, 2010; Shirasuna et al., 2012). The transforming growth factors beta (TGFβ) Despite its essential role in reproduction, the cellular and are local factors produced by ovarian cells which, after molecular mechanisms mediating CL regression are not binding to their receptors, regulate follicular deviation fully understood. It is well established that CLs are not fully and ovulation. However, their regulation and function responsive to PGF until day 5-6 after ovulation, whereas during corpus luteum (CL) regression has been poorly after days 15-17, in the absence of gestation, spontaneous investigated. The present study evaluated the mRNA luteolysis occurs. Thus, performing PGF treatment on day regulation of some TGFβ family ligands and their receptors 10 after ovulation represents an adequate model to study in the bovine CL during induced luteolysis in vivo. On day CL regression, because all the CLs are fully responsive to 10 of the estrous cycle, cows received an injection of PGF and still functional.
    [Show full text]
  • Follistatin and Noggin Are Excluded from the Zebrafish Organizer
    DEVELOPMENTAL BIOLOGY 204, 488–507 (1998) ARTICLE NO. DB989003 Follistatin and Noggin Are Excluded from the Zebrafish Organizer Hermann Bauer,* Andrea Meier,* Marc Hild,* Scott Stachel,†,1 Aris Economides,‡ Dennis Hazelett,† Richard M. Harland,† and Matthias Hammerschmidt*,2 *Max-Planck Institut fu¨r Immunbiologie, Stu¨beweg 51, 79108 Freiburg, Germany; †Department of Molecular and Cell Biology, University of California, 401 Barker Hall 3204, Berkeley, California 94720-3204; and ‡Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, New York 10591-6707 The patterning activity of the Spemann organizer in early amphibian embryos has been characterized by a number of organizer-specific secreted proteins including Chordin, Noggin, and Follistatin, which all share the same inductive properties. They can neuralize ectoderm and dorsalize ventral mesoderm by blocking the ventralizing signals Bmp2 and Bmp4. In the zebrafish, null mutations in the chordin gene, named chordino, lead to a severe reduction of organizer activity, indicating that Chordino is an essential, but not the only, inductive signal generated by the zebrafish organizer. A second gene required for zebrafish organizer function is mercedes, but the molecular nature of its product is not known as yet. To investigate whether and how Follistatin and Noggin are involved in dorsoventral (D-V) patterning of the zebrafish embryo, we have now isolated and characterized their zebrafish homologues. Overexpression studies demonstrate that both proteins have the same dorsalizing properties as their Xenopus homologues. However, unlike the Xenopus genes, zebrafish follistatin and noggin are not expressed in the organizer region, nor are they linked to the mercedes mutation. Expression of both genes starts at midgastrula stages.
    [Show full text]
  • The Role of the TGF- Co-Receptor Endoglin in Cancer
    1 The role of the TGF- co-receptor endoglin in cancer Eduardo Pérez-Gómez1,†, Gaelle del Castillo1, Juan Francisco Santibáñez2, Jose Miguel López-Novoa3, Carmelo Bernabéu4 and 1,* Miguel Quintanilla . 1Instituto de Investigaciones Biomédicas Alberto Sols, Consejo Superior de Investigaciones Científicas (CSIC)-Universidad Autónoma de Madrid, 28029-Madrid, Spain; 2Institute for Medical Research, University of Belgrado, Belgrado, Serbia; 3Instituto Reina Sofía de Investigación Nefrológica, Departamento de Fisiología y Farmacología, Universidad de Salamanca, Salamanca, Spain; 4Centro de Investigaciones Biológicas, CSIC, and CIBER de Enfermedades Raras (CIBERER), Madrid, Spain. E-mails: [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected] † Current address: Departamento de Bioquímica y Biología Molecular I, Facultad de Biología, Universidad Complutense de Madrid, Madrid, Spain *Corresponding author 2 ABSTRACT Endoglin (CD105) is an auxiliary membrane receptor of transforming growth factor- (TGF-) that interacts with type I and type II TGF- receptors and modulates TGF- signalling. Mutations in endoglin are involved in Hereditary Hemorrhagic Telangiectasia type I, a disorder characterized by cutaneous telangiectasias, epistaxis (nosebleeds) and major arteriovenous shunts, mainly in liver and lung. Endoglin is overexpressed in the tumor-associated vascular endothelium where it modulates angiogenesis. This feature makes endoglin a promising target for antiangiogenic cancer therapy. Recent studies on human and experimental models of carcinogenesis point to an important tumor cell-autonomous role of endoglin by regulating proliferation, migration, invasion and metastasis. These studies suggest that endoglin behaves as a suppressor of malignancy in experimental and human carcinogenesis. In this review, we evaluate the implication of endoglin in tumor development underlying studies developed in our laboratories in recent years.
    [Show full text]
  • Downloaded from Bioscientifica.Com at 10/03/2021 07:38:50PM Via Free Access
    229 3 <V>:<Iss> X ZHOU and others Gonadotrope-specific Bmpr1a 229229:3:3 331–341 Research knockout mice Normal gonadotropin production and fertility in gonadotrope- specific Bmpr1a knockout mice Xiang Zhou1,2, Ying Wang1,2, Luisina Ongaro1,2, Ulrich Boehm3, Vesa Kaartinen4, Yuji Mishina4 and Daniel J Bernard1,2 1Department of Pharmacology and Therapeutics, McGill University, Montreal, Québec, Canada 2Centre for Research in Reproduction and Development, McGill University, Montreal, Québec, Canada Correspondence 3Department of Pharmacology and Toxicology, University of Saarland School of Medicine, Homburg, Germany should be addressed 4Department of Biologic and Materials Sciences, School of Dentistry, University of Michigan, Ann Arbor, to D J Bernard Michigan, USA Email [email protected] Abstract Pituitary follicle-stimulating hormone (FSH) synthesis is regulated by transforming Key Words growth factor β superfamily ligands, most notably the activins and inhibins. Bone f pituitary morphogenetic proteins (BMPs) also regulate FSHβ subunit (Fshb) expression in f FSH immortalized murine gonadotrope-like LβT2 cells and in primary murine or ovine f bone morphogenetic Endocrinology primary pituitary cultures. BMP2 signals preferentially via the BMP type I receptor, protein of BMPR1A, to stimulate murine Fshb transcription in vitro. Here, we used a Cre–lox f activin receptor-like kinase approach to assess BMPR1A’s role in FSH synthesis in mice in vivo. Gonadotrope- Journal f Cre-lox specific Bmpr1a knockout animals developed normally and had reproductive organ weights comparable with those of controls. Knockouts were fertile, with normal serum gonadotropins and pituitary gonadotropin subunit mRNA expression. Cre-mediated recombination of the floxed Bmpr1a allele was efficient and specific, as indicated by PCR analysis of diverse tissues and isolated gonadotrope cells.
    [Show full text]
  • Inhibitory Effects of Activin on the Growth and Morphogenesis of Primary and Transformed Mammary Epithelial Cells'
    ICANCERRESEARCH56. I 155-I 163. March I. 19961 Inhibitory Effects of Activin on the Growth and Morphogenesis of Primary and Transformed Mammary Epithelial Cells' Qiu Yan Liu, Birunthi Niranjan, Peter Gomes, Jennifer J. Gomm, Derek Davies, R. Charles Coombes, and Lakjaya Buluwela2 Departments of Medical Oncology (Q. Y. L, P. G.. J. J. G., R. C. C., L B.J and Biochemistry (Q. Y. L. L B.J. Charing Cross and Westminster Medical School, Fuiham Palace Road. London W6 8RF; Division of Cell Biology and Experimental Pathology. Institute of Cancer Research, 15 Cotswald Rood, Sutton. Surrey SM2 SNG (B. NJ; and FACS Analysis Laboratory. imperial Cancer Research Fund, Lincoln ‘sInnFields. London WC2A 3PX (D. DI, United Kingdom ABSTRACT logical activities of activin. Indeed, two types of activin receptors have aLready been identified in the mouse (28) and several forms in Activin Is a member of the transforming growth factor fi superfamily, Xenopus (29, 30). The sequences of the Act-RI! (3 1), the TGF-@ type which is known to have activities Involved In regulating differentiation II receptor (32), the TGF-f3 type I receptor (33), and various activin and development. By using reverse transcrlption.PCR analysis on immu noafflnity.purlfied human breast cells, we have found that activin IJa and receptor-like genes (34) have been described. The comparison of these activin type II receptor are expressed by myoepithelial cells, whereas no sequences shows that they belong to a newly defined family of expression was detected In other breast cell types. In examining 15 breast membrane-bound, ligand-activated serine-threonine kinases (35).
    [Show full text]
  • Transforming Growth Factor-Β Soluble Receptor III (TGF-Β Sriii)
    Transforming Growth Factor-b Soluble Receptor III (TGF-b sRIII) Human, Recombinant Expressed in mouse NSO cells Product Number T4567 Product Description Reagent Transforming Growth Factor-b soluble Receptor III Recombinant human TGF-b sRIII is supplied as (TGF-b sRIII) is produced from a DNA sequence approximately 100 mg of protein lyophilized from a encoding the amino terminal (781 amino acid residue) 0.2 mm filtered solution in phosphate buffered saline extracellular domain of human TGF-b receptor type III (PBS) containing 5 mg of bovine serum albumin. protein.1 Mature human TGF-b sRIII, a 760 amino acid residue protein generated after cleavage of a 21 amino Preparation Instructions acid residue signal peptide, has a predicted molecular Reconstitute the contents of the vial using sterile mass of approximately 84 kDa. As a result of glycosy- phosphate-buffered saline (PBS) containing at least lation, recombinant TGF-b sRIII migrates as a 100 kDa 0.1% human serum albumin or bovine serum albumin. protein in SDS-PAGE. Prepare a stock solution of no less than 20 mg/ml. The transforming growth factor-b (TGF-b) family of Storage/Stability cytokines are multifunctional peptides; capable of Store at -20 °C. Upon reconstitution, store at 2 °C to influencing cell proliferation, growth, differentiation, and 8 °C for one month. For extended storage, freeze in other functions in a wide range of cell types. Most working aliquots. Repeated freezing and thawing is not mammalian cells express three abundant high affinity recommended. Do not store in a frost-free freezer. TGF receptors, which can bind and be cross-linked to 2 TGF-b.
    [Show full text]
  • Transforming Growth Factor-Β: a Multifunctional Regulator of Cancer Immunity
    cancers Review Transforming Growth Factor-β: A Multifunctional Regulator of Cancer Immunity 1, 1, 1 Vivian Weiwen Xue y , Jeff Yat-Fai Chung y, Cristina Alexandra García Córdoba , Alvin Ho-Kwan Cheung 1, Wei Kang 1 , Eric W.-F. Lam 2 , Kam-Tong Leung 3, Ka-Fai To 1, Hui-Yao Lan 4 and Patrick Ming-Kuen Tang 1,* 1 Department of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong 999077, China; [email protected] (V.W.X.); jeff[email protected] (J.Y.-F.C.); [email protected] (C.A.G.C.); [email protected] (A.H.-K.C.); [email protected] (W.K.); [email protected] (K.-F.T.) 2 Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital Campus, London W12 0NN, UK; [email protected] 3 Department of Paediatrics, The Chinese University of Hong Kong, Shatin, Hong Kong 999077, China; [email protected] 4 Department of Medicine and Therapeutics, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong 999077, China; [email protected] * Correspondence: [email protected] These authors contributed equally to this work. y Received: 24 September 2020; Accepted: 12 October 2020; Published: 23 October 2020 Simple Summary: Transforming growth factor beta (TGF-β) is a multifunctional cytokine that can restrict cancer onset but also promote cancer progression at late stages of cancer. The ability of TGF-β in producing diverse and sometimes opposing effects relies on its potential to control different cellular signalling and gene expression in distinct cell types, and environmental settings.
    [Show full text]